Johnson & Johnson Revenue 2006-2020 | JNJ

Johnson & Johnson annual/quarterly revenue history and growth rate from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Johnson & Johnson revenue for the quarter ending March 31, 2020 was $20.691B, a 3.35% increase year-over-year.
  • Johnson & Johnson revenue for the twelve months ending March 31, 2020 was $82.729B, a 1.39% increase year-over-year.
  • Johnson & Johnson annual revenue for 2019 was $82.059B, a 0.59% increase from 2018.
  • Johnson & Johnson annual revenue for 2018 was $81.581B, a 6.71% increase from 2017.
  • Johnson & Johnson annual revenue for 2017 was $76.45B, a 6.34% increase from 2016.
Johnson & Johnson Annual Revenue
(Millions of US $)
2019 $82,059
2018 $81,581
2017 $76,450
2016 $71,890
2015 $70,074
2014 $74,331
2013 $71,312
2012 $67,224
2011 $65,030
2010 $61,587
2009 $61,897
2008 $63,747
2007 $61,095
2006 $53,324
2005 $50,514
Johnson & Johnson Quarterly Revenue
(Millions of US $)
2020-03-31 $20,691
2019-12-31 $20,747
2019-09-30 $20,729
2019-06-30 $20,562
2019-03-31 $20,021
2018-12-31 $20,394
2018-09-30 $20,348
2018-06-30 $20,830
2018-03-31 $20,009
2017-12-31 $20,195
2017-09-30 $19,650
2017-06-30 $18,839
2017-03-31 $17,766
2016-12-31 $18,106
2016-09-30 $17,820
2016-06-30 $18,482
2016-03-31 $17,482
2015-12-31 $17,811
2015-09-30 $17,102
2015-06-30 $17,787
2015-03-31 $17,374
2014-12-31 $18,254
2014-09-30 $18,467
2014-06-30 $19,495
2014-03-31 $18,115
2013-12-31 $18,355
2013-09-30 $17,575
2013-06-30 $17,877
2013-03-31 $17,505
2012-12-31 $17,558
2012-09-30 $17,052
2012-06-30 $16,475
2012-03-31 $16,139
2011-12-31 $16,255
2011-09-30 $16,005
2011-06-30 $16,597
2011-03-31 $16,173
2010-12-31 $15,644
2010-09-30 $14,982
2010-06-30 $15,330
2010-03-31 $15,631
2009-12-31 $16,551
2009-09-30 $15,081
2009-06-30 $15,239
2009-03-31 $15,026
2008-12-31 $15,182
2008-09-30 $15,921
2008-06-30 $16,450
2008-03-31 $16,194
2007-12-31 $15,957
2007-09-30 $14,970
2007-06-30 $15,131
2007-03-31 $15,037
2006-12-31 $13,682
2006-09-30 $13,287
2006-06-30 $13,363
2006-03-31 $12,992
2005-12-31 $12,610
2005-09-30 $12,310
2005-06-30 $12,762
2005-03-31 $12,832
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $371.399B $82.059B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Roche Holding AG (RHHBY) Switzerland $299.895B 0.00
Novartis AG (NVS) Switzerland $200.421B 15.66
Merck (MRK) United States $198.849B 14.40
Pfizer (PFE) United States $191.697B 11.90
Eli Lilly (LLY) United States $156.734B 25.37
Novo Nordisk (NVO) Denmark $156.265B 26.02
AbbVie (ABBV) United States $146.020B 10.73
AstraZeneca (AZN) United Kingdom $141.191B 29.08
Sanofi (SNY) $129.264B 14.96
GlaxoSmithKline (GSK) United Kingdom $103.401B 12.34
Bayer (BAYRY) Germany $70.202B 10.01
H Lundbeck (HLUYY) Denmark $7.753B 13.47
Innoviva (INVA) United States $1.417B 8.18